These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 34417396)

  • 1. Progressive Improvement in Static Glabellar Lines After Repeated Treatment With DaxibotulinumtoxinA for Injection.
    Glogau R; Kontis TC; Liu Y; Gallagher CJ
    Dermatol Surg; 2021 Dec; 47(12):1579-1584. PubMed ID: 34417396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DaxibotulinumtoxinA for Injection for the Treatment of Glabellar Lines: Results from Each of Two Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Studies (SAKURA 1 and SAKURA 2).
    Carruthers JD; Fagien S; Joseph JH; Humphrey SD; Biesman BS; Gallagher CJ; Liu Y; Rubio RG; ;
    Plast Reconstr Surg; 2020 Jan; 145(1):45-58. PubMed ID: 31609882
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Immunogenicity of DaxibotulinumtoxinA for Injection in Glabellar Lines: Pooled Data from the SAKURA Phase 3 Trials.
    Gallagher CJ; Bowsher RR; Clancy A; Dover JS; Humphrey S; Liu Y; Prawdzik G
    Toxins (Basel); 2023 Jan; 15(1):. PubMed ID: 36668880
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunogenicity of DaxibotulinumtoxinA for Injection in Glabellar Lines.
    Humphrey S; Dover JS; Bowsher RR; Clancy A; Liu Y; Prawdzik G; Gallagher CJ
    Aesthet Surg J; 2023 Sep; 43(10):1189-1193. PubMed ID: 37051886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of DaxibotulinumtoxinA for Injection on Brow Position and Frontalis Muscle Activity Following Treatment of Glabellar Lines.
    Solish N; Kane MAC; Biesman BS; Brown J; Gallagher CJ
    Aesthet Surg J; 2023 Nov; 43(Suppl 1):S1-S9. PubMed ID: 36095026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of Glabellar Injection Technique With DaxibotulinumtoxinA for Injection on Brow Position.
    Bertucci V; Green JB; Fezza JP; Brown J; Gallagher CJ; Solish N
    Aesthet Surg J; 2023 Nov; 43(Suppl 1):S10-S18. PubMed ID: 36322141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bridging the Gap: Sustained Treatment Effect of Glabellar Lines With Twice-A-Year Treatment With DaxibotulinumtoxinA.
    Dover JS; Solish N; Gross TM; Gallagher CJ; Brown J
    Dermatol Surg; 2023 Sep; 49(9):862-864. PubMed ID: 37384899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Repeated OnabotulinumtoxinA Treatment of Glabellar Lines at Rest Over Three Treatment Cycles.
    Carruthers A; Carruthers J; Fagien S; Lei X; Kolodziejczyk J; Brin MF
    Dermatol Surg; 2016 Sep; 42(9):1094-101. PubMed ID: 27427996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LetibotulinumtoxinA Attenuates the Psychological Burden of Glabellar Lines and Is Associated With High Subject Satisfaction in Phase 3 Clinical Trials.
    Cox SE; Kaufman-Janette J; Cohen JL; Gold M; Joseph J; Nestor MS; Rzany B; Taylor S; Zhou J; Cecerle M; Pueraro E; Irvine R; Dayan S
    Dermatol Surg; 2024 Jun; 50(6):535-541. PubMed ID: 38470985
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and Safety of DaxibotulinumtoxinA for Injection in Cervical Dystonia: ASPEN-1 Phase 3 Randomized Controlled Trial.
    Comella CL; Jankovic J; Hauser RA; Patel AT; Banach MD; Ehler E; Vitarella D; Rubio RG; Gross TM;
    Neurology; 2024 Feb; 102(4):e208091. PubMed ID: 38295339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treating glabellar lines with botulinum toxin type A-hemagglutinin complex: a review of the science, the clinical data, and patient satisfaction.
    De Boulle K; Fagien S; Sommer B; Glogau R
    Clin Interv Aging; 2010 Apr; 5():101-18. PubMed ID: 20458348
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Phase III Clinical Study of the Efficacy and Safety of Botulinum Toxin Type A (MASPORT) with DYSPORT for the Treatment of Glabellar Lines.
    Hedayat K; Ehsani AH
    Aesthetic Plast Surg; 2024 Feb; 48(3):324-332. PubMed ID: 38233684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DaxibotulinumtoxinA (Daxxify) for frown lines.
    Med Lett Drugs Ther; 2024 Jul; 66(1707):e121-e122. PubMed ID: 39008109
    [No Abstract]   [Full Text] [Related]  

  • 14. PrabotulinumtoxinA for the Treatment of Moderate-to-Severe Glabellar Lines in Adult Patients With Skin of Color: Post Hoc Analyses of the US Phase III Clinical Study Data.
    Taylor SC; Grimes PE; Joseph JH; Jonker A; Avelar RL
    Dermatol Surg; 2021 Apr; 47(4):516-521. PubMed ID: 33165078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Second of Two One-Year, Multicenter, Open-Label, Repeat-Dose, Phase II Safety Studies of PrabotulinumtoxinA for the Treatment of Moderate to Severe Glabellar Lines in Adult Patients.
    Lorenc ZP; Adelglass JM; Avelar RL; Baumann L; Beer KR; Cohen JL; Cox SE; Dayan SH; Dover JS; Downie JB; Draelos ZD; Goldman MP; Gross JE; Joseph JH; Kaufman-Janette J; Moy RL; Nestor M; Schlessinger J; Smith SR; Weiss RA
    Aesthet Surg J; 2021 Nov; 41(12):1423-1438. PubMed ID: 33944913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of botulinum toxin type A on the healing of facial skin biopsies - series of cases.
    Padulla GA; Bagatin E; Hirata SH; Yarak S
    An Bras Dermatol; 2018; 93(4):610-611. PubMed ID: 30066781
    [No Abstract]   [Full Text] [Related]  

  • 17. Biochemical Stability and Microbial Control of Reconstituted DaxibotulinumtoxinA-lanm for Injection.
    Ellis K; Thach T; Gallagher CJ
    Toxins (Basel); 2023 Dec; 15(12):. PubMed ID: 38133187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surgical Procedures of the Correction of Severe Static Glabellar Lines by Utilizing Resection with Free Dermal Fat Grafting (FDFG).
    Dong G; Chen F; Zhang S; Yan T; Jia Y; Chang Y
    Aesthetic Plast Surg; 2024 Apr; ():. PubMed ID: 38587672
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Achieving Durable Forehead Line Outcomes With DaxibotulinumtoxinA: Early Experience in Real-World Clinical Practice.
    Lafkas M
    Aesthet Surg J Open Forum; 2024; 6():ojae023. PubMed ID: 38828476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and Duration of Effect of 40U PrabotulinumtoxinA-xvfs for the Treatment of Moderate to Severe Glabellar Lines in Adult Patients: A Phase II, Multi-Center, Randomized, Double Blind, Active-Controlled Trial.
    Fagien S; Avelar RL; Cox SE; Joseph JH; Kaufman-Janette J; Marcus KA
    Aesthet Surg J; 2024 Mar; ():. PubMed ID: 38506148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.